Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLA2G16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRIM33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPM2AIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPP30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SKIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYHR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXNDC11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SENP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MSRB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2N - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C3orf52 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OXR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC16A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on